{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:53:29Z","timestamp":1790434409151,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Connecticut Research Foundation"},{"name":"Office of Undergraduate Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.pbb.2015.10.008","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T09:48:39Z","timestamp":1445420919000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism"],"prefix":"10.1016","volume":"140","author":[{"given":"Samantha J.","family":"Podurgiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7491-5743","authenticated-orcid":false,"given":"Tiahna","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotem","family":"Kovner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younis","family":"Baqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merce","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2015.10.008_bb0005","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/gps.949","article-title":"Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia","volume":"18","author":"Aarsland","year":"2003","journal-title":"Int. J. Geriat. Psychiat."},{"issue":"4","key":"10.1016\/j.pbb.2015.10.008_bb0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-2007-985336","article-title":"Differentiating Parkinson's disease from other Parkinsonian disorders","volume":"27","author":"Alvarez","year":"2007","journal-title":"Semin. Neurol."},{"issue":"10","key":"10.1016\/j.pbb.2015.10.008_bb0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2169\/internalmedicine.39.863","article-title":"Parkinsonism onset in a patient currently using tiapride and donepzil","volume":"39","author":"Arai","year":"2000","journal-title":"Intern. Med."},{"key":"10.1016\/j.pbb.2015.10.008_bb0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1440-1819.2008.01877.x","article-title":"Postural-induced tremor in psychiatry","volume":"26","author":"Arbaizar","year":"2008","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2015.10.008_bb0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/01.WNL.0000073136.00548.D4","article-title":"Adenosine A(2A) receptor antagonist treatment of Parkinson's disease","volume":"61","author":"Bara-Jimenez","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pbb.2015.10.008_bb0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.expneurol.2010.12.022","article-title":"Preclinical jockeying on the translational track of adenosine A2A receptors","volume":"228","author":"Barkhoudarian","year":"2011","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.pbb.2015.10.008_bb0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0091-3057(93)90203-6","article-title":"Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine","volume":"46","author":"Baskin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2015.10.008_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0091-3057(94)90446-4","article-title":"Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding","volume":"49","author":"Baskin","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2015.10.008_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2009.05.040","article-title":"Effects of adenosine A2A antagonist KW-6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide","volume":"163","author":"Betz","year":"2009","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.pbb.2015.10.008_bb0050","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.neubiorev.2013.03.007","article-title":"Behavioral testing regimens in genetic-based animal models of Parkinson's disease: cogencies and caveats","volume":"37","author":"Bury","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2015.10.008_bb0055","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1073\/pnas.98.4.1970","article-title":"The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice","volume":"98","author":"Chen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2015.10.008_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(03)00178-5","article-title":"The adenosine A2A antagonist KF17837 reverses locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism","volume":"148","author":"Correa","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2015.10.008_bb0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pbb.2009.11.011","article-title":"Cholinomimetic-induced tremulous jaw movements are suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX: possible relevance for drug-induced parkinsonism","volume":"94","author":"Collins","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0070","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pbb.2011.05.026","article-title":"Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease","volume":"99","author":"Collins","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2015.10.008_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pbb.2011.10.015","article-title":"The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade","volume":"100","author":"Collins","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0080","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0306-4522(95)00407-6","article-title":"Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation","volume":"70","author":"Cousins","year":"1996","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pbb.2015.10.008_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0031-9384(98)00021-3","article-title":"Behavioural and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements","volume":"64","author":"Cousins","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004691-199603000-00002","article-title":"Clinical neurophyslogical iology of tremor","volume":"13","author":"Deuschl","year":"1996","journal-title":"J. Clin. Neurophysiol."},{"issue":"Suppl. 5","key":"10.1016\/j.pbb.2015.10.008_bb0095","doi-asserted-by":"crossref","first-page":"V\/33","DOI":"10.1007\/PL00007781","article-title":"The pathophysiology of parkinsonian tremor: a review","volume":"247","author":"Deuschl","year":"2000","journal-title":"J. Neurol."},{"issue":"24","key":"10.1016\/j.pbb.2015.10.008_bb0100","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.pbb.2015.10.008_bb0105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine\u2013dopamine receptor\u2013receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pbb.2015.10.008_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1353-8020(00)00063-8","article-title":"Adenosine\/dopamine interaction: implications for the treatment of Parkinson's disease","volume":"7","author":"Ferr\u00e9","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pbb.2015.10.008_bb0115","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/138161208784480108","article-title":"An update on adenosine A2A\u2013dopamine D2 receptor interactions: implications for the function of G-protein coupled receptors","volume":"14","author":"Ferr\u00e9","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbb.2015.10.008_bb0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0091-3057(96)00385-1","article-title":"Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions","volume":"57","author":"Finn","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.physbeh.2007.05.034","article-title":"Adenosine receptor\u2013dopamine receptor interactions in the basal ganglia and their relevance for brain function","volume":"92","author":"Fuxe","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0130","first-page":"534","article-title":"Tremor, the cogwheel phenomenon and clonus in Parkinson's disease","volume":"44","author":"Findley","year":"1981","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.pbb.2015.10.008_bb0135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-4522(97)00087-0","article-title":"Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats","volume":"80","author":"Finn","year":"1998","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pbb.2015.10.008_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp.2008.144048","article-title":"A double blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease","volume":"80","author":"Grace","year":"2009","journal-title":"J. Neurol. Neurochir. Psychiatr."},{"key":"10.1016\/j.pbb.2015.10.008_bb0145","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1021\/jo0358574","article-title":"Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease","volume":"69","author":"Hockemeyer","year":"2004","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.pbb.2015.10.008_bb0150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pbb.2004.12.006","article-title":"Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats","volume":"80","author":"Ishiwari","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12640-009-9011-7","article-title":"Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease","volume":"15","author":"Kasture","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pbb.2015.10.008_bb0160","series-title":"Design and Analysis: A Researcher's Handbook","author":"Keppel","year":"1991"},{"key":"10.1016\/j.pbb.2015.10.008_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pbb.2014.09.015","article-title":"Effects of cabergoline and rotigotine on tacrine-induced tremulous jaw movements in rats","volume":"126","author":"Koganemaru","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.21315","article-title":"Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces \u201coff\u201d time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005)","volume":"63","author":"LeWitt","year":"2008","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.pbb.2015.10.008_bb0175","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11055-008-9077-3","article-title":"Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial)","volume":"38","author":"Litvinenko","year":"2008","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.pbb.2015.10.008_bb0180","unstructured":"Marsden CD, Duvoisin RC, Jenner P, Parkes JD, Pycock C, Tarsy D. Relationship between animal models and clinical parkinsonism. Adv. Neurol. 1975; 9:165\u2013175."},{"issue":"5","key":"10.1016\/j.pbb.2015.10.008_bb0185","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00004714-198310000-00004","article-title":"The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs","volume":"3","author":"McEvoy","year":"1983","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2015.10.008_bb0190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14740338.5.6.759","article-title":"Drug-induced parkinsonism","volume":"5","author":"Mena","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.pbb.2015.10.008_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2007.05.008","article-title":"Effects of zonisamide on experimental tremors in rats","volume":"14","author":"Miwa","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pbb.2015.10.008_bb0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.parkreldis.2008.02.008","article-title":"Effects of zonisamide on c-Fos expression underconditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect","volume":"15","author":"Miwa","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pbb.2015.10.008_bb0205","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/mds.25418","article-title":"Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease","volume":"28","author":"Mizuno","year":"2013","journal-title":"Mov. Disord."},{"issue":"49","key":"10.1016\/j.pbb.2015.10.008_bb0210","doi-asserted-by":"crossref","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","article-title":"Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression","volume":"33","author":"Nunes","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2015.10.008_bb0215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0079-6123(10)83010-9","article-title":"Pathophysiological roles for purines: adenosine, caffeine and urate","volume":"183","author":"Morelli","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pbb.2015.10.008_bb0220","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00002826-199208000-00008","article-title":"Exacerbation of Parkinsonism by tacrine","volume":"15","author":"Ott","year":"1992","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pbb.2015.10.008_bb0225","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/syn.20410","article-title":"Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease","volume":"61","author":"Pinna","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2015.10.008_bb0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuroscience.2013.07.008","article-title":"The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor","volume":"250","author":"Podurgiel","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2015.10.008_bb0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2013.01.015","article-title":"Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor","volume":"105","author":"Podurgiel","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pbb.2015.10.008_bb0240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00178508","article-title":"Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat","volume":"88","author":"Salamone","year":"1986","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2015.10.008_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0091-3057(95)00164-6","article-title":"Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonism tremor","volume":"53","author":"Salamone","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.pbb.2015.10.008_bb0250","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0301-0082(98)00053-7","article-title":"Tremulous jaw movements in rats: a model of parkinsonian tremor","volume":"56","author":"Salamone","year":"1998","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.pbb.2015.10.008_bb0255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbr.2004.05.019","article-title":"Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of parkinsonism: tremerolytic effects of pergolide, ropinirole, and CY 208-243","volume":"156","author":"Salamone","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2015.10.008_bb0260","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.2741\/2952","article-title":"Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism","volume":"13","author":"Salamone","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pbb.2015.10.008_bb0265","doi-asserted-by":"crossref","unstructured":"Salamone JD, Ishiwari K, Betz AJ, Farrar AM, Mingote SM, Font L, Hockemeyer J, M\u00fcller CE, Correa M. Dopamine\/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism. Parkinsonism Relat. Disord. 2008b; 14:S130\u20134.","DOI":"10.1016\/j.parkreldis.2008.04.017"},{"issue":"8","key":"10.1016\/j.pbb.2015.10.008_bb0270","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.euroneuro.2012.08.004","article-title":"Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor","volume":"23","author":"Salamone","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2015.10.008_bb0275","series-title":"Movement Disorders Genetics and Models","first-page":"631","article-title":"Physiological and behavioral assessment of tremor in rodents","author":"Salamone","year":"2015"},{"key":"10.1016\/j.pbb.2015.10.008_bb0280","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pbb.2012.06.009","article-title":"The novel adenosine A2A antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions","volume":"102","author":"Santerre","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0285","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1041610298005341","article-title":"Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients","volume":"10","author":"Shea","year":"1998","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.pbb.2015.10.008_bb0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.pbb.2015.10.008_bb0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","article-title":"Parkinson's disease: genetics and pathogenesis","volume":"6","author":"Shulman","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.pbb.2015.10.008_bb0300","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2004.05.027","article-title":"Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions","volume":"189","author":"Simola","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2015.10.008_bb0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2006.05.038","article-title":"Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease","volume":"248","author":"Simola","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.pbb.2015.10.008_bb0310","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.parkreldis.2008.01.003","article-title":"Donepezil-induced jaw tremor","volume":"14","author":"Song","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.pbb.2015.10.008_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131281","article-title":"Targeted overexpression of \u03b1-synuclein by rAAV2\/1 vectors induces progressive nigrostriatal degeneration and increases vulnerability to MPTP in mouse","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pbb.2015.10.008_bb0320","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02257414","article-title":"Vacuous jaw movements induced by subchronic administration of haloperidol: interactions with scopolamine","volume":"111","author":"Steinpreis","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2015.10.008_bb0325","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(99)00011-8","article-title":"Distribution, biochemistry and function of striatal adenosine A2A receptors","volume":"59","author":"Svenningsson","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2015.10.008_bb0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pbb.2009.07.001","article-title":"Differential effects of adenosine antagonists in two models of parkinsonian tremor","volume":"94","author":"Trevitt","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.008_bb0335","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2007.03.021","article-title":"Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats","volume":"566","author":"Tronci","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.pbb.2015.10.008_bb0340","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1755-5949.2010.00166.x","article-title":"Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data","volume":"17","author":"van Laar","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pbb.2015.10.008_bb0345","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/syn.1070","article-title":"SCH 58261, an A2A adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats","volume":"41","author":"Wardas","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2015.10.008_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2015.01.012","article-title":"Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum","volume":"131C","author":"Yasuda","year":"2015","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T10:52:03Z","timestamp":1537267923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305715300800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":70,"alternative-id":["S0091305715300800"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2015.10.008","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2015.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}